The Therapeutic Effect of Adding Dextromethorphan to Clonidine for Reducing Symptoms of Opioid Withdrawal: A Randomized Clinical Trial
ISRN Psychiatry · 2013
DOI: 10.1155/2013/546030 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift ISRN Psychiatry, 2013. Verfasst von Ayyoub Malek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Psychiatry Research Center (CPRC), Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Tabriz University of Medical Sciences.
Abstract (Originalsprache)
Background
Dextromethorphan is a noncompetitive N-methyl D-aspartate receptor antagonist that is clinically feasible for relieving the opioid withdrawal symptoms. This study compares the efficacy of a combination therapy with dextromethorphan and clonidine to treatment with clonidine alone. Methods and Materials . In this double-blind randomized clinical trial, patients were selected from inpatients of detox and rehabilitation ward of Razi Hospital, Tabriz, Iran. They were randomly allocated to two groups receiving either clonidine (0.4–1.2 mg/day) or clonidine and dextromethorphan (300 mg/day). Withdrawal symptoms were evaluated in the first day of admission and again 24, 48, and 72 hours later.
Results
Thirty male patients completed the trial in each group. Withdrawal symptoms began to decrease in the second day in patients receiving dextromethorphan and clonidine while patients receiving clonidine experienced the more severe symptoms in 72 hours. Analysis of variance of the symptom severity score revealed a significant group × time interaction ( F = 14.25 ; P < 0.001 ), so that patients receiving dextromethorphan plus clonidine had milder symptoms during three days in all of the measurements compared to clonidine group.
Conclusion
Combination therapy of dextromethorphan and clonidine would result in milder opioid withdrawal symptoms compared to clonidine alone with a reduction beginning at the second day.
Autor:innen und Institutionen
- Clinical Psychiatry Research Center (CPRC), Tabriz University of Medical Sciences, Tabriz, Iran.
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Malek, A., Amiri, S., & Habibi Asl, B. (2013). The Therapeutic Effect of Adding Dextromethorphan to Clonidine for Reducing Symptoms of Opioid Withdrawal: A Randomized Clinical Trial. ISRN Psychiatry. https://doi.org/10.1155/2013/546030
Vancouver
Malek A, Amiri S, Habibi Asl B. The Therapeutic Effect of Adding Dextromethorphan to Clonidine for Reducing Symptoms of Opioid Withdrawal: A Randomized Clinical Trial. ISRN Psychiatry. 2013. doi:10.1155/2013/546030
BibTeX
@article{Malek2013,
author = {Malek, Ayyoub and Amiri, Shahrokh and Habibi Asl, Bohlool},
title = {The Therapeutic Effect of Adding Dextromethorphan to Clonidine for Reducing Symptoms of Opioid Withdrawal: A Randomized Clinical Trial},
journal = {ISRN Psychiatry},
year = {2013},
doi = {10.1155/2013/546030}
}
EUVIMED